This is the default blog subtitle.
The European Medicines Agency entered into the phase 3 of its business continuity plan(BCP) on 1 October 2018. This allows the Agency to safeguard core activities related to the evaluation and supervision of medicines, while it has to intensify its preparations for the physical move to Amsterdam in March 2019 and cope with significant staff […]
Read MoreA proposal for a Regulation of the European Parliament and of the council on the manufacture, placing on the market and use of medicated feed and repealing Council directive 90/167/CEE was presented by the European Commissionin 2014 and it is now in the later stage for approval. The proposal legislation aims to regulate the manufacture, […]
Read MoreHow EMA monitors medicines once they are on the market After its authorization a medicine is used by many patients, often together with other medicines. After some time, certain side effects may emerge that have not previously been identified because no medicine is a 100% safe. It is therefore essential that the safety of all […]
Read MoreThe European Medicines Agency (EMA) and the European Commission are currently providing guidance to help pharmaceutical companies responsible for medicines to be prepared for the UK withdrawal from the EUwhich will become a third country as of 30 March 2019. The objective is to ensure that companies are ready to take the necessary steps to enable undisrupted supply of their medicines […]
Read MoreBusiness continuity plan aims to preserve Agency’s ability to protect public and animal health The European Medicines Agency (EMA) has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom’s (UK’s) withdrawal from the European Union (EU) and the Agency’s relocation. The business continuity plan is a […]
Read MoreThe European Medicines Agency (EMA) is a decentralised agency of the European Union (EU) located in London, which is responsible for the scientific evaluation, supervision and safety monitoring of medicines for use in the EU. EMA protects human and animal health in 28 EU Member States (MS’s), as well as the countries of the European […]
Read More